{"transactions":[{"id":1775516,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Performance Right","published_at":"2023-09-21T21:17:23.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":11782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 11,782 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 7,539 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 11,782 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 7,539 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 11,782 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 7,539 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11782},"source":{"system":"sec-edgar","filing":"0001140361-23-044837","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123044837/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775515,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-09-21T21:17:23.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2716,"price":8.92,"value":24226.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,716 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":62951,"source":{"system":"sec-edgar","filing":"0001140361-23-044837","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123044837/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775514,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-09-21T21:17:23.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":7539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 7,539 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":65667,"source":{"system":"sec-edgar","filing":"0001140361-23-044837","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123044837/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1822876,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Performance Right","published_at":"2023-07-26T21:32:32.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":11782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11782},"source":{"system":"sec-edgar","filing":"0001140361-23-036319","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123036319/form4.xml","form_type":"4"}},{"id":1822875,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-26T21:32:32.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1230,"price":8.92,"value":10971.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,230 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":60313,"source":{"system":"sec-edgar","filing":"0001140361-23-036319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123036319/form4.xml","form_type":"4"}},{"id":1822874,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-26T21:32:32.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,415 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":61543,"source":{"system":"sec-edgar","filing":"0001140361-23-036319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123036319/form4.xml","form_type":"4"}},{"id":1823598,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-25T19:06:59.000Z","date":"2023-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":255,"price":8.65,"value":2205.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 255 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":58128,"source":{"system":"sec-edgar","filing":"0001140361-23-036118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123036118/form4.xml","form_type":"4"}},{"id":1823597,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-25T19:06:59.000Z","date":"2023-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":333,"price":8.74,"value":2910.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 333 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":58383,"source":{"system":"sec-edgar","filing":"0001140361-23-036118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123036118/form4.xml","form_type":"4"}},{"id":1824928,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-21T21:11:19.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":21913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 19, 2024, such that 25% of the options will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":21913,"derivative":{"exercise_price":8.92,"exercise_date":"2024-07-19","expiration_date":"2033-07-19","underlying":"Common Stock","underlying_shares":21913},"source":{"system":"sec-edgar","filing":"0001140361-23-035727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123035727/form4.xml","form_type":"4"}},{"id":1824927,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Performance Right","published_at":"2023-07-21T21:11:19.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":21176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":21176,"derivative":{"underlying":"Common Stock","underlying_shares":21176},"source":{"system":"sec-edgar","filing":"0001140361-23-035727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123035727/form4.xml","form_type":"4"}},{"id":1824926,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-21T21:11:19.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":10588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 10,588 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 10,588 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2024, such that 25% of the restricted stock units will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":58716,"source":{"system":"sec-edgar","filing":"0001140361-23-035727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123035727/form4.xml","form_type":"4"}},{"id":1827923,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-18T20:13:30.000Z","date":"2023-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":351,"price":9.56,"value":3355.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 351 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":48128,"source":{"system":"sec-edgar","filing":"0001140361-23-035084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123035084/form4.xml","form_type":"4"}},{"id":1827922,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"officer":true,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2023-07-18T20:13:30.000Z","date":"2023-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":517,"price":9.63,"value":4978.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 517 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":48479,"source":{"system":"sec-edgar","filing":"0001140361-23-035084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000114036123035084/form4.xml","form_type":"4"}},{"id":2203388,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2022-07-22T18:28:04.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":8680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 20, 2023, such that 25% of the options will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":8680,"derivative":{"exercise_price":21.53,"exercise_date":"2023-07-20","expiration_date":"2032-07-20","underlying":"Common Stock","underlying_shares":8680},"source":{"system":"sec-edgar","filing":"0001567619-22-014365","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761922014365/doc1.xml","form_type":"4"}},{"id":2203387,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Performance Right","published_at":"2022-07-22T18:28:04.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":7410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":7410,"derivative":{"underlying":"Common Stock","underlying_shares":7410},"source":{"system":"sec-edgar","filing":"0001567619-22-014365","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761922014365/doc1.xml","form_type":"4"}},{"id":2203386,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2022-07-22T18:28:04.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":3705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 3,705 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,705 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 20, 2023, such that 25% of the restricted stock units will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":48996,"source":{"system":"sec-edgar","filing":"0001567619-22-014365","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761922014365/doc1.xml","form_type":"4"}},{"id":2456288,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-30T17:57:48.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":7721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of performance rights and stock options of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance rights and the exercise price of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":7721,"derivative":{"exercise_price":26.49,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":7721},"source":{"system":"sec-edgar","filing":"0001567619-21-022711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921022711/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2456287,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Performance Right","published_at":"2021-12-30T17:57:48.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":5684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of performance rights and stock options of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance rights and the exercise price of the options."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of common stock of the Company (\"Common Stock\"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of common stock of the Company (\"Common Stock\"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of common stock of the Company (\"Common Stock\"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":5684,"derivative":{"underlying":"Common Stock","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001567619-21-022711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921022711/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2523162,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP/GM, Global VIT"}}],"security":"Common Stock","published_at":"2021-11-05T16:28:43.000Z","date":"2021-10-31","kind":"tax_withholding","acquired":false,"shares":953,"price":29.37,"value":27989.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 953 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on October 31, 2019."}],"balance_after":45291,"source":{"system":"sec-edgar","filing":"0001567619-21-019404","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921019404/doc1.xml","form_type":"4"}},{"id":2540712,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP/GM, Global VIT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-10-18T16:45:10.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options for one-fourth of the shares became exercisable on 10/24/2015, 10/24/2016, 10/24/2017 and 10/24/2018, respectively."}],"balance_after":0,"derivative":{"exercise_price":16.77,"exercise_date":"2015-10-24","expiration_date":"2024-10-24","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-21-018407","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921018407/doc1.xml","form_type":"4"}},{"id":2540711,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP/GM, Global VIT"}}],"security":"Common Stock","published_at":"2021-10-18T16:45:10.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":12000,"price":27.92,"value":335040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.85 to $27.99, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."}],"balance_after":46244,"source":{"system":"sec-edgar","filing":"0001567619-21-018407","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921018407/doc1.xml","form_type":"4"}},{"id":2540710,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP/GM, Global VIT"}}],"security":"Common Stock","published_at":"2021-10-18T16:45:10.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":12000,"price":16.77,"value":201240.0,"ownership":{"direct":true},"balance_after":58244,"source":{"system":"sec-edgar","filing":"0001567619-21-018407","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921018407/doc1.xml","form_type":"4"}},{"id":2624031,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP/GM, Global VIT"}}],"security":"Common Stock","published_at":"2021-07-27T19:05:33.000Z","date":"2021-07-26","kind":"tax_withholding","acquired":false,"shares":419,"price":26.1,"value":10935.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 419 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":46244,"source":{"system":"sec-edgar","filing":"0001567619-21-014064","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921014064/doc1.xml","form_type":"4"}},{"id":2626071,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-23T18:47:47.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":7721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":7721,"derivative":{"exercise_price":10.27,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":7721},"source":{"system":"sec-edgar","filing":"0001567619-21-013923","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921013923/doc1.xml","form_type":"4"}},{"id":2626070,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Performance Right","published_at":"2021-07-23T18:47:47.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":5684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":5684,"derivative":{"underlying":"Common Stock","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001567619-21-013923","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921013923/doc1.xml","form_type":"4"}},{"id":2626069,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2021-07-23T18:47:47.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":2842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The acquisition of 2,842 shares of Common Stock  of the Company represents 2,842 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":46663,"source":{"system":"sec-edgar","filing":"0001567619-21-013923","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921013923/doc1.xml","form_type":"4"}},{"id":2626068,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2021-07-23T18:47:47.000Z","date":"2021-07-18","kind":"tax_withholding","acquired":false,"shares":344,"price":24.76,"value":8517.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 344 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":43821,"source":{"system":"sec-edgar","filing":"0001567619-21-013923","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921013923/doc1.xml","form_type":"4"}},{"id":2626067,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2021-07-23T18:47:47.000Z","date":"2021-07-17","kind":"tax_withholding","acquired":false,"shares":339,"price":24.76,"value":8393.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 339 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":44165,"source":{"system":"sec-edgar","filing":"0001567619-21-013923","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921013923/doc1.xml","form_type":"4"}},{"id":2626066,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2021-07-23T18:47:47.000Z","date":"2021-07-14","kind":"tax_withholding","acquired":false,"shares":500,"price":26.43,"value":13215.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 500 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":44504,"source":{"system":"sec-edgar","filing":"0001567619-21-013923","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761921013923/doc1.xml","form_type":"4"}},{"id":2995044,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":109524,"kind":"person","name":"Centea Scott","position":1,"cik":"0001823973","reported_name":"Centea Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, VIT"}}],"security":"Common Stock","published_at":"2020-11-03T16:22:00.000Z","date":"2020-10-31","kind":"tax_withholding","acquired":false,"shares":849,"price":10.62,"value":9016.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 849 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on October 31, 2019."}],"balance_after":45004,"source":{"system":"sec-edgar","filing":"0001567619-20-018615","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823973/000156761920018615/doc1.xml","form_type":"4"}}]}